Clinicopathological Correlates of IgM Paraproteinemias

Clinical Lymphoma

Volumn 1, Issue 1, 2000, Pages 39-43

  Owen, Roger G ^a,b   Parapia, Liakat A ^b   Higginson, Jean ^a   Misbah, Siraj A ^a   Child, J Anthony ^a   Morgan, Gareth J ^a   Jack, Andrew S ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b BRADFORD ROYAL INFIRMARY   (United Kingdom)

Author keywords

IgM paraprotein; Non Hodgkin's lymphoma; Waldenstr m's macroglobulinemia

Indexed keywords

CANCER ANTIBODY; IMMUNOGLOBULIN M; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; PARAPROTEIN;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; PARAPROTEINEMIA; WALDENSTROEM MACROGLOBULINEMIA; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, CD; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN M; IMMUNOPHENOTYPING; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; MALE; MIDDLE AGED; PARAPROTEINEMIAS; PARAPROTEINS; WALDENSTROM MACROGLOBULINEMIA; WORLD HEALTH ORGANIZATION;

EID: 0034208482     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2000.n.003     Document Type: Article

References (26)

1. Waldenstrom J. Incipient myelomatosis or essential hyperglobulinemia with fibrinogenopenia - a new syndrome? Acta Med Scand 1944; 117:216-247.
2. Dimopoulos MA, Alexanian R. Waldenström's macroglobulinemia. Blood 1994; 83:1452-1459.
3. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, et al. Waldenström's macroglobulinemia: clinical features, complications, and management. J Clin Oncol 2000; 18:214-226.
4. Herrinton LJ, Weiss NS. Incidence of Waldenström's macroglobulinemia. Blood 1993; 82:3148-3150.
5. Gertz MA, Kyle RA, Noel P. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenstrom's macroglobulinemia. J Clin Oncol 1993; 11:914-920.
6. Owen RG, Parapia LA, Richards SJ, et al. Waldenstrom's macroglobulinemia: development of diagnostic criteria and identification of prognostic factors. J Clin Oncol (submitted).
7. Owen RG, Lubenko A, Savage J, et al. Autoimmune thrombocytopenia in Waldenstrom's macroglobulinemia. Am J Hematol (submitted).
8. Stone MJ. Studies on monoclonal antibodies. The specificity and binding properties of a Waldenstrom macroglobulin with anti-γ activity. J Lab Clin Med 1973; 81:393-409.
9. Stone MJ, Fedak JE. Studies on monoclonal antibodies II. Immune complex (IgM-IgG) cryoglobulinemia: the mechanism of cryoprecipitation. J Immunol 1974; 113:1377-1385.
10. Moore DF, Migliore PJ, Shullenberger CC, et al. Monoclonal macroglobulinemia in malignant lymphoma. Am Int Med 1970; 72:43-47.
11. Kyle RA, Garton JP. The spectrum of IgM monclonal gammopathy in 430 cases. Mayo Clin Proc 1987; 62:719-731.
12. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-1392.
13. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17:3835-3849.
14. Owen RG, Parapia LA, Richards SJ, et al. Paraprotein status in lymphoplasmacytoid lymphoma/immunocytoma: do all cases correspond to Waldenstrôm's macroglobulinaemia? Brit J Haematol 1999; 105 (suppl 1): 89a (Abstract #239).
15. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol 1989; 42:567-584.
16. Facon T, Brouillard M, Duhamel A, et al. Prognostic factors in Waldenstrom's macroglobulinemia: a report of 167 cases. J Clin Oncol 1993; 11:1553-1558.
17. Gobbi PG, Bettini R, Montecucco C, et al. Study of prognosis in Waldenstrom's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility. Blood 1994; 83:2939-2945.
18. Bartl R, Frisch B, Mahl G, et al. Bone marrow histology in Waldenstrom's macroglobulinaemia. Clinical relevance of subtype recognition. Scand J Haematol 1983; 31:359-375.
19. Matutes E, Owusu-Ankormah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8:1640-1645.
20. Papamichael D, Norton AJ, Foran JM, et al. Immunocytoma: a retrospective analysis from St. Bartholomews Hospital - 1972 to 1996. J Clin Oncol 1999; 17:2847-2853.
21. De Wolf-Peeters C, Pittaluga S, Dierlamm J, et al. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone. Leuk Lymphoma 1997; 26:467-478.
22. Wagner SD, Martinelli V, Luzzatto L. Similar patterns of Vkappa gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma. Blood 1994; 83:3647-3653.
23. Aoki H, Takishita M, Kosaka M, et al. Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenstrom's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL. Blood 1995; 85:1913-1919.
24. Stevenson F, Sahota S, Zhu D, et al. Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes. Immunol Rev 1998; 162:247-259.
25. Ivanovski M, Silvestri F, Pozzato G, et al. Somatic hypermutation, clonal-diversity, preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998; 91:2433-2442.
26. Berger F, Felman P, Thieblemont C, et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 2000; 95:1950-1956.